These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14704888)

  • 1. Base rate of Hiscock Digit Memory Test failure in HIV-associated neurocognitive disorders.
    Woods SP; Conover E; Weinborn M; Rippeth JD; Brill RM; Heaton RK; Grant I;
    Clin Neuropsychol; 2003 Aug; 17(3):383-9. PubMed ID: 14704888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms in nonlitigant patients.
    Merten T; Bossink L; Schmand B
    J Clin Exp Neuropsychol; 2007 Apr; 29(3):308-18. PubMed ID: 17454351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center.
    Plummer DJ; Marcotte TD; Sample PA; Wolfson T; Heaton RK; Grant I; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):435-42. PubMed ID: 9950603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive impairment in early HIV-positive individuals.
    Mandal N; Singh OP; Bhattacharya S; Chatterji S; Biswas A; Sen S
    J Indian Med Assoc; 2008 Jul; 106(7):442, 447-9, 453. PubMed ID: 18975499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between performances on neuropsychological symptom validity testing and the MCMI-III in patients with fibromyalgia.
    Brooks L; Johnson-Greene D; Lattie E; Ference T
    Clin Neuropsychol; 2012; 26(5):816-31. PubMed ID: 22420469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Coin-in-the-Hand Test and dementia: more evidence for a screening test for neurocognitive symptom exaggeration.
    Schroeder RW; Peck CP; Buddin WH; Heinrichs RJ; Baade LE
    Cogn Behav Neurol; 2012 Sep; 25(3):139-43. PubMed ID: 22960438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
    Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
    AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screening algorithm for HIV-associated neurocognitive disorders.
    Cysique LA; Murray JM; Dunbar M; Jeyakumar V; Brew BJ
    HIV Med; 2010 Nov; 11(10):642-9. PubMed ID: 20456505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.
    Carey CL; Woods SP; Gonzalez R; Conover E; Marcotte TD; Grant I; Heaton RK;
    J Clin Exp Neuropsychol; 2004 May; 26(3):307-19. PubMed ID: 15512922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of WMT, CARB, and TOMM failure rates in non-head injury disability claimants.
    Gervais RO; Rohling ML; Green P; Ford W
    Arch Clin Neuropsychol; 2004 Jun; 19(4):475-87. PubMed ID: 15163449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. California Verbal Learning Test indicators of suboptimal performance in a sample of head-injury litigants.
    Slick DJ; Iverson GL; Green P
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):569-79. PubMed ID: 11094392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample.
    Woods SP; Scott JC; Dawson MS; Morgan EE; Carey CL; Heaton RK; Grant I;
    Arch Clin Neuropsychol; 2005 Dec; 20(8):1061-71. PubMed ID: 16198529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of injury severity and cognitive exaggeration on olfactory deficits in head injury compensation claims.
    Green P; Iverson GL
    NeuroRehabilitation; 2001; 16(4):237-43. PubMed ID: 11790910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
    Kessels RP; Mimpen G; Melis R; Rikkert MG
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of below-chance performance in forced-choice symptom validity tests.
    Greve KW; Binder LM; Bianchini KJ
    Clin Neuropsychol; 2009 Apr; 23(3):534-44. PubMed ID: 19221937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.